Skip to main content

WOWI, Inc. (WOWU)

New York Stock Exchange Healthcare Drug Manufacturers - Specialty & GenericView data quality →
49.3Fair

ValueMarkers Composite Index

Top 29%#31,961 of 44,714
Undervalued

100% below intrinsic value ($0)

UndervaluedFair ValueOvervalued
Piotroski
2/9
Weak
Beneish
-3.20
Low Risk
Altman
-4.75
Distress
DCF Value
$0
Undervalued
ROIC
2.3%
Low
P/E
0.1
Value
Updated: ·Source: Data sourced from SEC filings and institutional providers. Not financial advice.·Report data issue

WOWI, Inc. (WOWU) — VMCI valuation read

WOWU prints VMCI 49/100 inside the Healthcare sector, where the median sits at 50. The 1-point below-median delta is the cleanest single-number summary of WOWI, Inc.'s composite stance, and in the mid-cap bucket it places the share behind the typical peer on the five-pillar mix.

On WOWU, the SEC EDGAR Form 4 stream shows no insider buys or sells in the past 30 days. Quiet tapes happen; they just remove a signal that bull and bear cases sometimes lean on for confirmation.

**Investor frame.** WOWU trades at 26.0x earnings, 44% above the Healthcare median of 18.0x; that is the value line. ROIC of 18.0% sits 8.0pp above the Healthcare median (10.0%); that is the quality line. net debt to EBITDA of 2.0x is the rate-sensitivity line to watch; that is the risk line for WOWI, Inc. on the trailing financials.

WOWU rose 3.4% over the trailing 7 days, with a -13.7% read on a 30-day basis.

Top peers ranked by VM Score. Compare valuation, quality, and risk metrics across the sector.

Browse More

Weekly Stock Analysis - Free

5 undervalued stocks, fully modeled. Every Monday. No spam.

Cookie Preferences

We use cookies to analyze site usage and improve your experience. You can accept all, reject all, or customize your preferences.